The impact of dyslipidaemia on cardiovascular mortality in individuals without a prior history of diabetes in the DECODE Study

被引:27
作者
Zhang, Lei [1 ,2 ]
Qiao, Qing [1 ,2 ]
Tuomilehto, Jaakko [1 ,2 ]
Hammar, Niklas [3 ,4 ]
Ruotolo, Giacomo [4 ,5 ]
Stehouwer, Coen D. A. [6 ]
Heine, Robert J. [7 ,8 ]
Eliasson, Mats [9 ]
Zethelius, Bjorn [10 ]
机构
[1] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland
[2] Natl Inst Hlth & Welf, Diabet Prevent Unit, Dept Chron Dis Prevent, Helsinki, Finland
[3] Karolinska Inst, Inst Environm Med, Dept Epidemiol, S-10401 Stockholm, Sweden
[4] AstraZeneca R&D, Molndal, Sweden
[5] Ist Sci San Raffaele, Div Metab & Cardiovasc Dis, I-20132 Milan, Italy
[6] Maastricht Univ, Med Ctr, Dept Internal Med, Az Maastricht, Netherlands
[7] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[8] Eli Lilly & Co, Indianapolis, IN 46285 USA
[9] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden
[10] Univ Uppsala Hosp, Dept Publ Hlth Geriatr, Uppsala, Sweden
基金
芬兰科学院;
关键词
Lipid; IGT; IFG; Hyperglycaemia; Cardiovascular disease; Mortality; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN-CHOLESTEROL; IMPAIRED FASTING GLUCOSE; NON-HDL CHOLESTEROL; RISK-FACTORS; DIAGNOSTIC-CRITERIA; INSULIN-RESISTANCE; METABOLIC SYNDROME; NONFASTING TRIGLYCERIDES; MYOCARDIAL-INFARCTION;
D O I
10.1016/j.atherosclerosis.2008.12.043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the impact of dyslipidaemia on cardiovascular disease (CVD) mortality in relation to fasting (FPG) and 2-h (2hPG) plasma glucose levels in individuals without a prior history of diabetes. Methods: Data from 14 European population-based prospective studies of 9132 men and 8631 women aged 25-89 years were jointly analysed. A total of 871 CVD deaths occurred during the average 10 years of follow-up. Subjects were classified into normoglycaemia, isolated fasting hyperglycaemia (IFH, FPG >= 6.10 mmol/l and 2hPG < 7.80 mmol/l), isolated post-load hyperglycaemia (IPH, FPG < 6.10 mmol/l and 2hPG >= 7.80 mmol/l) and combined fasting and post-load hyperglycaemia (CH, FPG >= 6.10 mmol/l and 2hPG >= 7.80 mmol/l). Multivariate-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for CVD mortality were estimated using Cox proportional hazard analysis. Results: Multivariate-adjusted HRs (95% CIs) for high-density lipoprotein cholesterol (HDL-C) were 0.84 (0.75-0.94), 0.66 (0.48-0.92), 1.03 (0.84-1.27) and 0.67 (0.51-0.89) in individuals with normoglycaemia, IFH, IPH and CH, respectively. For total cholesterol (TC) to HDL-C ratio they were 1.14 (1.03-1.27), 1.44 (1.13-1.84), 0.94 (0.77-1.15) and 1.26 (1.05-1.50), respectively. HRs for TC and triglycerides (TG) were not significant in most of the glucose categories except for TG in those with CH [HR 1.12 (1.00-1.27)]. Conclusions: Low HDL-C and high TC/HDL-C increase CVD mortality in either diabetic or non-diabetic individuals defined based on the fasting glucose criteria, but not the 2-h criteria. TG is a significant CVD risk predictor only in the presence of combined hyperglycaemia or diabetes. The difference between fasting and post-load hyperglycaemia with regard to the lipid-CVD relation may suggest a different pathophysiology underlying these two prediabetic states. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:298 / 302
页数:5
相关论文
共 43 条
[1]   Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose [J].
Abdul-Ghani, MA ;
Tripathy, D ;
DeFronzo, RA .
DIABETES CARE, 2006, 29 (05) :1130-1139
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]   Postprandial inflammation and endothelial dysfuction [J].
Alipour, A. ;
Elte, J. W. F. ;
van Zaanen, H. C. T. ;
Rietveld, A. P. ;
Cabezas, M. Castro .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 :466-469
[5]   Do triglycerides provide meaningful information about heart disease risk? [J].
Avins, AL ;
Neuhaus, JM .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (13) :1937-1944
[6]   Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women [J].
Bansal, Sandeep ;
Buring, Julie E. ;
Rifai, Nader ;
Mora, Samia ;
Sacks, Frank M. ;
Ridker, Paul M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (03) :309-316
[7]   PLASMA-LIPIDS AND DIABETES-MELLITUS IN AN ADULT COMMUNITY [J].
BARRETTCONNOR, E ;
GRUNDY, SM ;
HOLDBROOK, MJ .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1982, 115 (05) :657-663
[8]   A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific Region [J].
Barzi, F ;
Patel, A ;
Woodward, M ;
Lawes, CMM ;
Ohkubo, T ;
Gu, D ;
Lam, TH ;
Ueshima, H ;
Gu, D ;
Lam, TH ;
Pan, W ;
Suh, I ;
Ueshima, H ;
Lawes, CMM ;
Rodgers, A ;
Woodward, M ;
Bennett, D ;
Parag, V ;
Xie, JX ;
Norton, R ;
Ameratunga, S ;
MacMahon, S ;
Whitlock, G ;
Knuiman, MW ;
Christensen, H ;
Zhou, J ;
Yu, XH ;
Gu, DF ;
Wu, XG ;
Tamakoshi, A ;
Pan, WH ;
Sritara, P ;
Wu, ZL ;
Chen, LQ ;
Shan, GL ;
Gu, DF ;
Duan, XF ;
MacMahon, S ;
Norton, R ;
Whitlock, G ;
Jackson, R ;
Li, YH ;
Lam, TH ;
Jiang, CQ ;
Fujishima, M ;
Kiyohara, Y ;
Iwamoto, H ;
Woo, J ;
Ho, SC ;
Hong, Z .
ANNALS OF EPIDEMIOLOGY, 2005, 15 (05) :405-413
[9]  
Boden WE., 2000, The American Journal of Cardiology, V86, P19, DOI DOI 10.1016/S0002-9149(00)01464-8
[10]  
Borch-Johnsen K, 1998, BMJ-BRIT MED J, V317, P371